Hematopoietic Fas Deficiency Does Not Affect Experimental Atherosclerotic Lesion Formation despite Inducing a Proatherogenic State
Authors:
- 1 June 2011
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 178 (6) , 2931-2937
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL080623, HL087165, HL018645)
This publication has 42 references indexed in Scilit:
- Membrane-bound Fas ligand only is essential for Fas-induced apoptosisNature, 2009
- Accelerated atherosclerosis in ApoE deficient lupus mouse modelsClinical Immunology, 2008
- Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine modelAtherosclerosis, 2008
- Enhanced Immune System Activation and Arterial Inflammation Accelerates Atherosclerosis in Lupus-Prone MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathwayJournal of Leukocyte Biology, 2007
- A Diet-Induced Hypercholesterolemic Murine Model to Study Atherogenesis Without Obesity and Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- ApoE−/−Fas−/− C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopeniaJournal of Lipid Research, 2007
- Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusArthritis & Rheumatism, 2001
- Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout MouseArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Flice-Inhibitory Protein Expression during Macrophage Differentiation Confers Resistance to FAS-Mediated ApoptosisJournal of Experimental Medicine, 1999